Kevin D. Kee,Ernest D. Penachio,Abhijit Kamerkar,Michael M. Lipp,Richard P. Batycky
申请号：
US14575454
公开号：
US09393210B2
申请日:
2014.12.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L. The invention further provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L wherein the capsule material comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide.
